[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 790 Introduced in House (IH)]
<DOC>
117th CONGRESS
1st Session
H. RES. 790
Expressing support for the designation of November 2021 as ``Pancreatic
Cancer Awareness Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 12, 2021
Mr. Carson (for himself, Ms. Eshoo, Mr. McKinley, Mrs. McClain, Mr.
Fitzpatrick, Mr. Danny K. Davis of Illinois, Ms. Norton, Mr. Cohen, Mr.
Keating, Ms. Moore of Wisconsin, and Ms. Lee of California) submitted
the following resolution; which was referred to the Committee on Energy
and Commerce, and in addition to the Committee on Armed Services, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of November 2021 as ``Pancreatic
Cancer Awareness Month''.
Whereas pancreatic cancer will kill an estimated 48,220 people in the United
States in 2021;
Whereas pancreatic cancer is the third leading cause of cancer-related death in
the United States;
Whereas, in 2020 and 2021, pancreatic cancer has killed three American icons--
Congressman John Lewis, Congressman Alcee Hastings, and Supreme Court
Justice Ruth Bader Ginsburg;
Whereas an additional 60,430 individuals in the United States will be diagnosed
with pancreatic cancer in 2021;
Whereas of those diagnosed with pancreatic cancer, 72 percent will die within
the first year of their diagnosis;
Whereas persistent health care inequities and disparities for communities of
color compound the devastation of pancreatic cancer;
Whereas the incidence rate for pancreatic cancer among Black Americans is 20
percent higher than that of any other racial demographic;
Whereas the pancreatic cancer death rate is 17 percent higher for Black men than
for White men;
Whereas the lack of pancreatic cancer early detection research accelerates the
racial unfairness in the United States health care system, with
devastating consequences for minorities;
Whereas pancreatic cancer has no early detection test to diagnose this cancer
quickly and accurately determine the presence of this cancer;
Whereas, if diagnosed early, the 5-year survival rate for pancreatic cancer
patients is above 80 percent;
Whereas if pancreatic cancer is detected late, the 5-year survival rate drops to
less than 10 percent;
Whereas without adequate funding and early detection research, pancreatic cancer
is not discovered until the late stages of this horrific cancer where
treatment options are limited;
Whereas in fiscal year 2020, pancreatic cancer received its own dedicated
research program at the Department of Defense under the Congressionally
Directed Medical Research Programs;
Whereas in the Department of Defense Appropriations Act, 2020 (division A of
Public Law 116-93), Congress appropriated funds to the Congressionally
Directed Medical Research Programs, with $6,000,000 going to the
Pancreatic Cancer Research Program;
Whereas during the consideration of H.R. 6395 (the National Defense
Authorization Act for Fiscal Year 2021), the House of Representatives
agreed to an amendment to the bill that was filed with the Committee on
Rules by Representative Carson of Indiana to increase the authorization
of funds by $5,000,000 for pancreatic cancer research, including an
early detection initiative, by the Department of Defense, and the House
of Representatives passed the bill with that amendment included;
Whereas during the consideration of H.R. 4350 (the National Defense
Authorization Act for Fiscal Year 2022), the House of Representatives
agreed to an amendment to the bill that was filed with the Committee on
Rules by Representative Carson, Representative Eshoo, and Representative
McKinley to increase the authorization of funds by $5,000,000 for
pancreatic cancer research, including an early detection initiative, by
the Department of Defense, and the House of Representatives passed the
bill with that amendment included;
Whereas during the consideration of H.R. 7617 (the Defense, Commerce, Justice,
Science, Energy and Water Development, Financial Services and General
Government, Homeland Security, Labor, Health and Human Services,
Education, Transportation, Housing, and Urban Development Appropriations
Act, 2021), the House of Representatives agreed to an amendment to the
bill that was filed with the Committee on Rules by Representative Carson
of Indiana and Representative Eshoo to increase the amount appropriated
for a pancreatic cancer early detection initiative from $10,000,000 to
$15,000,000, and the House of Representatives passed the bill with that
amendment included; and
Whereas the 117th Congress has a unique opportunity to make a historic
investment in pancreatic cancer research at the Department of Defense:
Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Pancreatic Cancer
Awareness Month'';
(2) recognizes the critical importance of increasing
funding for pancreatic cancer research at the Department of
Defense and the National Institutes of Health to find effective
treatments for this cancer and reduce the disproportionate
impact on communities of color; and
(3) supports the efforts of the many advocacy organizations
to educate communities in the United States about pancreatic
cancer and the need for more research funding, early detection
initiatives, diagnostic tests, and effective treatments.
<all>